These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26503201)

  • 1. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.
    Tao R; Krishnan S; Bhosale PR; Javle MM; Aloia TA; Shroff RT; Kaseb AO; Bishop AJ; Swanick CW; Koay EJ; Thames HD; Hong TS; Das P; Crane CH
    J Clin Oncol; 2016 Jan; 34(3):219-26. PubMed ID: 26503201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
    Hamamoto Y; Niino K; Ishiyama H; Hosoya T
    Radiat Med; 2004; 22(5):316-23. PubMed ID: 15553012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
    Brunner TB; Blanck O; Lewitzki V; Abbasi-Senger N; Momm F; Riesterer O; Duma MN; Wachter S; Baus W; Gerum S; Guckenberger M; Gkika E
    Radiother Oncol; 2019 Mar; 132():42-47. PubMed ID: 30825968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of conventional doses of chemoradiation for unresectable biliary cancer.
    Crane CH; Macdonald KO; Vauthey JN; Yehuda P; Brown T; Curley S; Wong A; Delclos M; Charnsangavej C; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):969-74. PubMed ID: 12095564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
    Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
    BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative radiotherapy for patients with unresectable or medically inoperable cholangiocarcinoma.
    Liu MY; Lo CH; Lin CS; Chao HL; Yang JF; Lin KT; Fan CY; Su YF; Huang WY
    Tumori; 2017 May; 103(3):236-241. PubMed ID: 28058710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
    Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
    Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
    Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.
    Elganainy D; Holliday EB; Taniguchi CM; Smith GL; Shroff R; Javle M; Raghav K; Kaseb A; Aloia TA; Vauthey JN; Tzeng CD; Herman JM; Koong AC; Krishnan SX; Minsky BD; Crane CH; Das P; Koay EJ
    Cancer Med; 2018 Oct; 7(10):4880-4892. PubMed ID: 30152073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-guided radiation therapy for liver tumors: gastrointestinal histology matters.
    Katsoulakis E; Riaz N; Cannon DM; Goodman K; Spratt DE; Lovelock M; Yamada Y
    Am J Clin Oncol; 2014 Dec; 37(6):561-7. PubMed ID: 23466584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
    Lee G; Kim DW; Smart AC; Horick NK; Eyler CE; Roberts HJ; Pathak P; Goyal L; Franses J; Heather JM; Hwang WL; Grassberger C; Klempner SJ; Drapek LC; Allen JN; Blaszkowsky LS; Parikh AR; Ryan DP; Clark JW; Hong TS; Wo JY
    Am J Clin Oncol; 2024 Aug; 47(8):373-382. PubMed ID: 38767086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
    Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.
    De B; Tran Cao HS; Vauthey JN; Manzar GS; Corrigan KL; Raghav KPS; Lee SS; Tzeng CD; Minsky BD; Smith GL; Holliday EB; Taniguchi CM; Koong AC; Das P; Javle M; Ludmir EB; Koay EJ
    Cancer; 2022 Jul; 128(13):2529-2539. PubMed ID: 35417569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study.
    Gil E; Joh JW; Park HC; Yu JI; Jung SH; Kim JM
    World J Surg Oncol; 2015 Jul; 13():227. PubMed ID: 26216347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma.
    Cho Y; Kim TH; Seong J
    Strahlenther Onkol; 2017 Aug; 193(8):620-629. PubMed ID: 28424838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conformal therapy of locally advanced cholangiocarcinoma of the main bile ducts].
    Bouras N; Caudry M; Saric J; Bonnel C; Rullier E; Trouette R; Demeaux H; Maire JP
    Cancer Radiother; 2002 Feb; 6(1):22-9. PubMed ID: 11899677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
    J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma.
    Lu JJ; Bains YS; Abdel-Wahab M; Brandon AH; Wolfson AH; Raub WA; Wilkinson CM; Markoe AM
    Cancer J; 2002; 8(1):74-8. PubMed ID: 11895206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.